The first criterion, consistency, requires that findings are consistent across different study types, in different locations and across different populations, for example, race/ethnicity. This is not evident for the association between vitamin D deficiency and MS.
The starkest example is in Asian populations. In China, the prevalence of MS is very low, 2 yet vitamin D deficiency (25OHD < 50 nmol/L) and insufficiency (<75 nmol/L) are common at 69% and 94%, respectively. 3 Similarly, the prevalence of vitamin D deficiency in the United States is 65%, 44% and 14% in blacks, Hispanics and whites, respectively; 4 this does not correspond to the incidence of MS. Compared to whites, the incidence of MS is less than half in Hispanics, over 80% lower in Asians and slightly higher in blacks residing in Southern California. 5 In the only multi-racial population-based study of 25OHD levels and incident MS, 6 there was a significant association in whites, but not in blacks or Hispanics, despite good sample size in all racial/ethnic groups. In a prospective cohort study using samples from the US Army serum repository, 25OHD levels were inversely associated with MS risk in whites, but not in blacks. 7 These inconsistencies are in stark contrast to smoking and lung cancer, where the associations are consistent globally across race/ethnicities in ecological, casecontrol and cohort studies.
'Strength' refers to the magnitude of the association. Strong associations, like the 20-fold increase in lung cancer in heavy smokers, are unlikely to be due to confounding. Focusing only on the evidence in whites and ignoring inconsistencies in how low or high 25OHD was defined, the increased risks of MS are of the order of two-to threefold, often with a lower confidence interval (CI) close to the null effect. For example, in the US Army serum repository, the odds ratio for a 50 nmol/L increment in 25OHD was 0.59 (95% CI: 0.36-0.97), equivalent to an odds ratio (OR) of 1.7 for a (huge) decrement of 50 nmol/L. 7 These relatively small effect sizes could be due to uncontrolled confounding, like smoking or body mass index.
Weak associations can be causal, but inference of causality requires other evidence, like a consistent doseresponse or threshold effect. For vitamin D and MS, studies report a threshold at inconsistent cut-points (>99 nmol/L 7 or >87 nmol/L 8 ), a linear dose response 7 or significant associations (for whites only) at all pre-determined cut-points. 6 These inconsistencies occur despite very similar distribution of serum 25OHD levels across studies. [6] [7] [8] The absolute requirement for a causal association is that the exposure (vitamin D deficiency) precedes the outcome (MS). This is challenging in MS because it is not clear when the inflammatory process begins 9 and inflammation may cause 25OHD levels to drop, 10 that is, even in cohort studies that measure 25OHD prior to diagnosis, low 25OHD may be disease induced.
The final criterion is coherence -across animal and human studies and what we know of biological pathways, the evidence collectively should make sense. This is clearly not achieved for vitamin D deficiency and MS. How can one explain the lack of association in blacks and Hispanics? Animal studies also show inconsistent findings in relation to physiological levels of 25OHD. 11, 12 Perhaps, the critical risk period is during childhood or adolescence, and this explains the inconsistent findings in adults. Sun or ultraviolet radiation (UVR) exposure has been used as a proxy since they are the primary sources of vitamin D. Higher lifetime UVR exposure was associated with reduced MS risk consistently across all racial/ethnic groups. 6 One could argue that this is indirect evidence that lifetime vitamin D status is associated with MS risk, even in blacks and Hispanics. However, the correlation between UVR and 25OHD levels is much weaker in blacks and Hispanics than in whites and, therefore, not necessarily a good indicator of vitamin D status. A coherent hypothesis is that vitamin D-independent immunological changes induced by UVR exposure reduce the risk of MS.
Mendelian randomization (MR) studies are promoted as confirming causality: lower genetically determined 25OHD levels (in white populations) are associated with a higher risk of MS. 13 We believe this interpretation is erroneous. The genetic variants used account for <10% of the variance in 25OHD levels, far less than UVR, obesity or diet, and focus on a sunlight pathway. Furthermore, 25OHD is an intermediate metabolite with little biological function; MR studies do not include genetic variants mediating the physiological effects of the active form of vitamin D. Finally, a fundamental assumption of MR is that the genetic variants influence the outcome only through the exposure (25OHD levels). At least one gene used in the MR may influence MS risk through vitamin D-independent mechanisms. 14 The myopic view is that MS affects only white people and only evidence supporting the vitamin D-MS hypothesis is valid. One could pick apart the lack of association between 25OHD and MS in blacks, Hispanics and Asians, much as the tobacco industry picked apart the evidence for smoking causing lung cancer. However, taking a global view, the most obvious coherent explanation is that low vitamin D does not cause MS and, at best, is a redundant pro-inflammatory co-factor in whites.
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